Clinical and genetic heterogeneity in a large cohort of Armenian patients with late-onset familial Mediterranean fever

This work aimed at investigating demographic, clinical, and genetic characteristics of individuals experiencing their first familial Mediterranean fever (FMF) attack at age ≥40 years in a very large cohort of Armenian FMF patients. In total, 10,370 Armenian patients diagnosed with FMF based on the T...

Full description

Saved in:
Bibliographic Details
Published inGenetics in medicine Vol. 20; no. 12; pp. 1583 - 1588
Main Authors Kriegshäuser, Gernot, Enko, Dietmar, Hayrapetyan, Hasmik, Atoyan, Stepan, Oberkanins, Christian, Sarkisian, Tamara
Format Journal Article
LanguageEnglish
Published New York Elsevier Inc 01.12.2018
Nature Publishing Group US
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This work aimed at investigating demographic, clinical, and genetic characteristics of individuals experiencing their first familial Mediterranean fever (FMF) attack at age ≥40 years in a very large cohort of Armenian FMF patients. In total, 10,370 Armenian patients diagnosed with FMF based on the Tel Hashomer criteria and carrying at least one MEFV mutant allele were included in this study. A total of 354 (3.40%) patients had late-onset FMF. Of these, 194 (54.80%) were female and 160 (45.20%) were male. The following genotypes were significantly associated with the late-onset variant: M680I/E148Q (P = 0.004), M694V/E148Q (P < 0.001), and V726A/V726A (P< 0.001). Of note, 12/354 (3.40%) patients were found to be homozygous for the M694V mutation. Individuals with late-onset FMF had a milder disease phenotype presenting significantly less frequent fever, skin manifestation, and chest pain compared to individuals with a disease onset before 40 years of age. Abdominal pain was found more often in the late-onset FMF group, whereas arthritis, proteinuria, and amyloidosis did not differ significantly between the two groups. Our data suggest that late-onset FMF is more prevalent in women and is of greater clinical as well as genetic heterogeneity than previously reported.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1098-3600
1530-0366
DOI:10.1038/gim.2018.46